Meihua International Medical Technologies Co., Ltd. — Cyborg Score 4/10
Mixed
Disposable medical devices manufacturing
Strategic Profile
The company's class A ordinary shares were suspended from Nasdaq in December 2025 and moved to OTC trading under symbol "MHUAF" after a Nasdaq Hearings Panel denied reinstatement on February 24, 2026. Since July 2025, the company launched a SaaS business through U.S. subsidiary Meihua Future Manufacturing Limited, focusing on medical registration and clinic information systems for North America, Hong Kong, and Southeast Asia. The SaaS segment contributed about 2.6% of total revenue for the year ended December 31, 2025 and remains in an early stage.
Cyborg Score Rationale
Meihua faces material headwinds: flat revenues (~$97M annually), OTC delisting in 2026, and narrow profitability margins. However, the company maintains decades of operational history in regulated medical devices and is diversifying into healthcare SaaS with signed contracts exceeding $16M. The delisting significantly constrains capital access and investor reach, offsetting SaaS growth potential.
Top Insights
In 2024, revenue was $96.91 million with earnings of $10.84 million, representing flat revenue and declining earnings year-over-year. Stagnant top-line growth signals market saturation or competitive pressure in disposable medical devices, raising questions about organic runway.
As of July 2026, Meihua reports cumulative signed contracts of USD 16.125 million for the new SaaS business. Early-stage healthcare SaaS contracts represent meaningful optionality but remain unproven at scale relative to base business size.
The company appealed a Nasdaq delisting decision via Hearings Panel (January 27, 2026), which was denied February 24, 2026, with a further internal Nasdaq review requested March 2, 2026. OTC status as of July 2026 significantly reduces liquidity and institutional investor access, creating structural headwinds.
Named Competitors
Medtronic — Global leader in disposable and advanced medical devices
B. Braun — Disposable medical devices and infusion systems
Becton Dickinson — Medical devices including examination gloves and infusion kits
Cardinal Health — Leading manufacturer and distributor of disposable medical devices and surgical supplies
Recent Developments
(July 2025) Launched healthcare SaaS business trial via U.S. subsidiary Meihua Future Manufacturing Limited
(December 2025) Nasdaq suspended trading; shares moved to OTC Marketplace under symbol MHUAF